Glasgow-based medical start-up Microplate Dx has successfully closed a £2.5 million seed funding round to accelerate the development of its point-of-care diagnostic platform. The technology aims to combat antimicrobial resistance (AMR) by quickly identifying the most effective antibiotics for
Sis Ventures
A Scottish agritech firm specialising in the next generation of green insecticides has secured a further round of investment totalling £4 million to scale up the development of its nature-inspired pesticides. Investment in SOLASTA Bio's pre-Series A funding round was led by Yield Lab Europe. O
Responsible finance provider Social Investment Scotland (SIS) has appointed community finance expert Arran Dewar as executive director of SIS Ventures. Mr Dewar joins SIS Ventures from Inspiring Scotland, a venture philanthropy organisation which aims to improve the lives people from disadvanta
Dxcover — a Glasgow-based company developing a blood test that can detect cancer at an early stage — has raised £9.7 million through a Series A investment round and grant funding. The £7.5m funding round was led by existing investors Eos Advisory LLP, Mercia Asset M
Edinburgh-based biotechnology start-up, MiAlgae, has secured further investment of £2.3m to help drive the next stage of its growth journey. Established in 2016, MiAlgae has created a solution to producing a sustainable source of Omega-3 for animal and human consumption – something which
Edinburgh-based life sciences company Carcinotech, a MedTech specialist in the manufacture of 3D printed tumours developed from cancer stem cells, primary cells, and established cell lines, has secured a £1.6 million investment from leading Scotland-based investors to accelerate commercialisat
Impact investor SIS Ventures has secured £1 million for its investment fund – Impact First - from Chroma Ventures. Chroma Ventures was created in 2021 by technology entrepreneurs Paddy Burns and Chris van der Kuyl as a broad-spectrum investment arm of their video game development studio,
Edinburgh-based ad tech company Good-Loop has closed a Series A round of £4.5 million. The funds will be used to accelerate the company’s product roadmap, including the development of new solutions aimed at reducing digital advertising’s substantial carbon footprint.
SIS Ventures has launched a second round of fundraising with the aim of attracting up to £5 million to scale up its support for Scotland’s high impact potential early-stage businesses. SIS Ventures’ Impact First fund provides the opportunity for investors to make tax-efficient fina
Glasgow-based Talking Medicines, the world’s first Artificial Intelligence (AI) driven patient intelligence company designed to meet the needs of pharma, has closed a £1.5 million funding round to support its ambitions for expansion into the US. Boston based life science investor Mark Ba
Trojan Energy, the clean energy company, has secured a late seed round investment of £2.2 million to roll out its unique, flat-and-flush on-street EV (electric vehicle) charging hubs and develop further commercial applications of its technology. The round was led by Scottish angel investors Eq
SOLSTA Bio, a Glasgow University spinout specialising in the next generation of green insecticides, has secured seed investment of £1.3 million to support ongoing development of its unique nature-inspired pesticides, the first of their kind to be developed worldwide. Investors in this seed fun
Social Investment Scotland (SIS) has appointed Siobhan Moore as an investment manager for its wholly-owned impact investment fund, SIS Ventures, supporting its continued growth amid increasing investor demand for mission-driven businesses. Siobhan Moore joins the impact investor from Finsbury Food G
Aberdeen-based green-tech start-up Trojan Energy has secured a £4.1 million round of seed funding to support the roll-out of its on-street flat and flush electric vehicle (EV) charging points.
Some of Scotland’s early-stage mission-led businesses are stepping up in the fight against COVID-19, as part of the business community’s pandemic response.